Get the Stockscreener App
40.71
2.33%
0.8521
Omnicell Inc stock is traded at $40.71, with a volume of 235.66K.
It is up +2.33% in the last 24 hours and up +3.29% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$39.86
Open:
$40.34
24h Volume:
235.66K
Relative Volume:
0.36
Market Cap:
$1.85B
Revenue:
$1.23B
Net Income/Loss:
$20.43M
P/E Ratio:
92.30
EPS:
0.4411
Net Cash Flow:
$95.39M
1W Performance:
-11.07%
1M Performance:
+3.29%
6M Performance:
-18.91%
1Y Performance:
+45.01%
1-Day Range:
$39.97
$41.10
1-Week Range:
$39.13
$45.97
52-Week Range:
$27.77
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
40.76 | 1.81B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
185.86 | 29.17B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
73.25 | 13.71B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
44.40 | 8.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.65 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
47.72 | 6.10B | 638.78M | -22.66M | 122.18M | -0.1744 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Price to book forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Price to book forward of Omnicell, Inc. – BX:OC9 - TradingView
Omnicell (OMCL) Stock Forum and Discussion - Moomoo
Omnicell to report Q2 earnings: OmniSphere in focus - MSN
Omnicell to Report Q2 Earnings: OmniSphere in Focus - Yahoo Finance
(OMCL) Risk Channels and Responsive Allocation - Stock Traders Daily
1 Healthcare Stock to Target This Week and 2 We Brush Off - Yahoo Finance
Omnicell CEO Randall Lipps Executes Sale of 10,000 Shares Under Pre-Arranged Rule 10b5-1 Plan - Kalkine Media
Omnicell (OMCL) chief reports 10,000-share sale at $47 via trust - Stock Titan
ETFs Investing in Omnicell, Inc. Stocks - TradingView
Press Release: Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 - 富途牛牛
Omnicell | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
OMNICELL, INC. SEC Filing (Jul 15, 2026) - Stock Titan
Does Omnicell’s ESOP Share Registration and Leadership Shift Reframe Its Capital Allocation Story (OMCL)? - simplywall.st
Omnicell (OMCL) up 0.1% since last earnings report: Can it continue? - MSN
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Omnicell (OMCL) - The Globe and Mail
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 - BioSpace
OMCL6251486 Bond Risk Profile - TradingView
OMCL6251486 Bond Profile — Key Metrics - TradingView
The Bull Case For Omnicell (OMCL) Could Change Following New President And ESOP Share Offering - Yahoo Finance
Omnicell to release Q2 2026 financial results on July 30 - scanx.trade
KeyBanc reiterates Omnicell stock rating on Titan XT launch By Investing.com - Investing.com South Africa
KeyBanc reiterates Omnicell stock rating on Titan XT launch - Investing.com
Should You Continue to Hold OMCL Stock in Your Portfolio Now? - TradingView
Fort Worth’s Omnicell Names Chief Operating Officer as President - Dallas Innovates
Enterprise value to revenue forward of Omnicell, Inc. – DUS:OC9 - TradingView
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - AOL.com
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business - AOL.com
Omnicell (NASDAQ:OMCL) Leadership Move Puts Automation Back - Kalkine Media
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year? - Yahoo Finance Singapore
Omnicell focuses on automation and medication management as investors track long term opportunities - Ad Hoc News
Does Omnicell's (OMCL) Leadership Shift and Index Move Reframe Its Healthcare Automation Narrative? - simplywall.st
Omnicell Jumps 7.8% Amid Sector-Wide Rally - AlphaStreet
OMCLOmnicell Inc Options - Finviz
Form 4 Omnicell Inc For: 6 July By Investing.com - Investing.com Canada
Omnicell (NASDAQ: OMCL) President & COO awarded 12,309 RSUs in promotion grant - Stock Titan
Enterprise value to EBIT forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
OMCL News | OMNICELL INC (NASDAQ:OMCL) - ChartMill
Wells Fargo Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Omnicell names Nnamdi Njoku as president - Medical Buyer
Omnicell Elevates COO Nnamdi Njoku to President - The Globe and Mail
Omnicell Appoints Nnamdi Njoku President, Retaining COO Role - Fort Worth Inc.
Omnicell, Inc. Announces Executive Changes - marketscreener.com
Omnicell Appoints Nnamdi Njoku as President, Stock Ticker OMCL - GuruFocus
Omnicell appoints Nnamdi Njoku as president effective today By Investing.com - Investing.com Nigeria
Nnamdi Njoku Appointed President of Omnicell - GuruFocus
Omnicell appoints Nnamdi Njoku as president effective today - Investing.com
Omnicell Promotes Nnamdi Njoku to President While Retaining COO Role - citybiz
Omnicell Names Nnamdi Njoku as President - Moomoo
Nnamdi Njoku appointed President of Omnicell (OMCL) while Randall Lipps remains CEO - Stock Titan
Omnicell: Njoku Will Retain His Role of COO >OMCL - Moomoo
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):